Tradestie Institutional Equity Comparison Engine
BIAF vs SHPH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SHPH Overall Edge
SHPH Captures Institutional Edge (2โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BIAF trades at N/M Forward P/E with -246.1% operating margin (-26.0% YoY revenue) versus SHPH at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BIAF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SHPH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BIAF N/M vs SHPH N/M Fwd P/E
Growth & Margin Winner
SHPH
Op Margin -246.1% vs 0.0% ยท YoY -26.0% vs +0.0%
Momentum & Technical Winner
SHPH
1Y +12.2% vs +76.3% ยท 52W Pos 7% vs 54%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BIAF
NASDAQ
bioAffinity Technologies, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.65
-10.81% 1D
Market Cap
$3.3M
1M Return
-47.95%
1Y Return
+12.24%
Forward P/E
N/M
Unified AI Score
48.0 / 100
HOLD
Tech 38.0
Fund 51.0
Flow 50.0
Mom 64.0
SHPH
NASDAQ
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
Pharmaceutical Preparations
$3.49
-10.51% 1D
Market Cap
$17.6M
1M Return
-24.3%
1Y Return
+76.26%
Forward P/E
N/M
Unified AI Score
48.3 / 100
HOLD
Tech 38.0
Fund 47.0
Flow 50.0
Mom 46.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BIAF +12.24%
SHPH +76.26%
Spread: +64.02 pp (SHPH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BIAF TTM Op. Margin: -246.1%
SHPH TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIAF vs SHPH. Trailing 12-month operating profitability (BIAF -246.1% vs SHPH 0.0%) and valuation multiples (BIAF N/M vs SHPH N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BIAF | SHPH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.3M | $17.6M | Larger Scale | SHPH |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -26.0% | +0.0% | Higher Growth | SHPH |
| Operating Margin (TTM) Profitability | -246.1% | 0.0% | Higher Margin | SHPH |
| Net Profit Margin Profitability | -278.9% | 0.0% | Higher Margin | SHPH |
| Return on Equity (ROE) Capital Efficiency | -240.5% | -90.0% | Higher ROE | SHPH |
| 52-Week Range Position Momentum | 7% ($0โ$20) | 54% ($0โ$6) | Stronger Trend | SHPH |
| Beta / 30D Volatility Risk Regime | -0.62ฮฒ ยท 120% Vol | 9.23ฮฒ ยท 88% Vol | Lower Realized Risk | SHPH |
| Unified Institutional Score Composite Signal | 48.0 / 100 (HOLD) | 48.3 / 100 (HOLD) | Higher Composite | SHPH |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BIAF vs SHPH Buy Guide
BIAF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SHPH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BIAF nor SHPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.